SENSE-Cog Residential CARE: hearing and vision support for residents with dementia

ISRCTN ISRCTN14462472
DOI https://doi.org/10.1186/ISRCTN14462472
Secondary identifying numbers 212073
Submission date
28/01/2022
Registration date
23/02/2022
Last edited
13/02/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Of the 55,000 people with dementia in Ireland, nearly 17,000 live in nursing homes (Irish care homes). Over 90% of these residents have significant hearing and vision problems that are frequently undetected or under-corrected. Poor sensory function can worsen quality of life for residents with dementia (RwD) by making communication more difficult and increasing confusion and challenging behaviour.

The study aims to ascertain the feasibility of delivery, acceptability and tolerability of a sensory support intervention in Irish nursing homes. To explore whether the sensory support intervention may be effective in improving quality of life and other outcomes for RwD and nursing home staff. To explore what Care as Usual looks like in nursing homes, and lastly, to evaluate cost-effectiveness parameters of the intervention. The findings from this study will inform progression to a definitive trial and contribute to emerging evidence of care home research methodology.

Who can participate?
The study aims to recruit approximately ten nursing homes across Ireland. Within each nursing home, we will recruit residents living with dementia to participate in this study. We will also recruit two staff members, who we will call sensory champions. These staff members will undergo staff training in sensory-cognitive healthcare.

What does the study involve?
The ten nursing homes that participate in the study will be split up into two groups. This will be a random process. Five will be allocated to the intervention group and five will be allocated to the care as usual (CAU) group. Those in the CAU group will receive care as usual within their care home setting. Those in the intervention group will receive the intervention on site, at the nursing home, by trained Sensory Champions (care home staff) selected from each care home. The sensory support intervention involves personalised resident sensory support, staff training, developing a ‘sensory friendly’ environment and ensuring optimal care pathways to hearing/vision providers.
In order to see if the intervention has any effect, we will look at aspects such as resident quality of life, functional ability, behaviour and cognition, culture of care and the sensory environment. A researcher who does not know whether the nursing home has received the intervention or not, will administer tests looking at these elements at baseline, 3, and 6 months. We will also examine if the intervention is feasible by looking at areas such as acceptability to staff, engagement and retention. The total duration of the intervention will be 12 weeks. Exploration of barriers and facilitators to intervention and trial delivery will inform future trial design.

What are the possible benefits and risks of participating?
There is reason to believe that staff in the intervention group will benefit professionally from the sensory cognitive health training provided. There is also reason to believe that RwD participants in the Intervention group will benefit directly from the activity, gaining further sensory support through participation. The intervention and evaluation will not pose any great risk onto the care homes, or individuals (staff and RwD) who consent to participant in this study.

Where is the study run from?
The research team is based at St James’s Hospital, Dublin, Ireland. Testing will be carried out off-cite at participating nursing homes (locations yet to be determined).

When is the study starting and how long is it expected to run for?
November 2021 to November 2023

Who is funding the study?
The Health Research Board (HRB), Dublin, Ireland

Who is the main contact?
Ann-Michelle Mullally, MULLALAN@tcd.ie

Study website

Contact information

Prof Iracema Leroi
Scientific

Mercer's Institute for Successful Ageing (MISA) St. James’s Hospital
Dublin
D08 E191
Ireland

ORCiD logoORCID ID 0000-0003-1822-3643
Phone +353 1 416 4528
Email iracema.leroi@tcd.ie
Ms Ann-Michelle Mulally
Public

Trinity College Dublin
College Green
Dublin
D02 PN40
Ireland

Phone +353 1 416 4528
Email MULLALAN@tcd.ie

Study information

Study designFeasibility-pilot cluster randomized controlled parallel-group observer-blind multicentre trial
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)Other
Study typeQuality of life
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleSENSE-Cog Residential CARE: A feasibility study of hearing and vision support to improve quality of life in care home residents with dementia
Study acronymSENSE-Cog Residential CARE
Study hypothesisThe study aims to ascertain feasibility of delivery, acceptability, and tolerability of a Sensory Support Intervention for hearing and vision function, for residents with dementia in care homes in Ireland.
Ethics approval(s)Approval 09/06/2022, Faculty of Health Sciences Research Ethics Committee (Trinity College Dublin)
(Faculty of Health Sciences, Chemistry Building, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland; +353 1 896 4193; ethicscommittee@tcd.ie), ref: 220402
ConditionSensory support for hearing and vision impairment in residents with dementia living in the care home setting
InterventionThere will be two study arms involving up to 10 nursing homes across Ireland, randomly allocated (1:1) to receive a complex intervention, the Sensory Support Intervention for care homes (SSI-C), or to continue Care as Usual (CAU). Randomisation will be conducted by the Clinical Trials' Facility at St James Hospital via secure web-based randomisation system.
Those in the CAU group will receive care as usual within their care home setting.
Those in the SSI-C group will receive the intervention by Sensory Champions (care home staff) selected from each care home. The SSI-C will involve personalised resident sensory support, staff training, developing a ‘sensory friendly’ environment and ensuring optimal care pathways to hearing/vision providers.
The total duration of treatment will be 12 weeks.
Assessments will be undertaken by a blinded researcher with all study arms at baseline, 3- and 6-month follow-up.
Intervention typeBehavioural
Primary outcome measure1. Feasibility to conduct the SSI-C in Irish care homes is measured using, the rate of recruitment of care homes, and retention rate of randomised homes and participants.
2. Feasibility of the intervention is measured using percentage staff agreeing to participate, staff reporting sufficient time to undertake the intervention, barriers, and facilitators of the intervention.
3. Acceptability/tolerability of the intervention is measured using Staff attendance, Residents’ adverse event (AE) rate related to the intervention and Staff perceptions of the training component using qualitative interviews and the Training Acceptability Rating Scale (TARS), pre-post training.
Secondary outcome measures1. Exploratory Outcome Set for Residents (EOS-R) measured using key dementia- and sensory- related outcomes including measures of quality of life at three time points: baseline and post-intervention (3- and 6-months).
2. Battery of Care home staff measures including sensory-cognitive health knowledge and change in staff practice, care home culture measured using self-report questionnaires and qualitative interviews at three time points: baseline and post-intervention (3- and 6-months).
3. Battery of Care Environment measures including sensory aspects such as the physical environment (light, temperature, and noise) using Screening Surveys and standardised assessment protocols at three time points: baseline and post-intervention (3- and 6-months).
Overall study start date08/11/2021
Overall study end date08/11/2023

Eligibility

Participant type(s)Mixed
Age groupMixed
SexBoth
Target number of participants10 care homes; 2 sensory champions (staff members) and 10 residents in each home
Participant inclusion criteria1. Care Home has at least 60% of residents with dementia.
2. Care Home must be ‘compliant’ or ‘substantially compliant’ based on HIQA reports.
3. Staff Is aged ≥18 years.
4. Staff Is a current member of staff in a participating care home and is involved in the care of the RwD (all grades including: Director of Nursing; nurses; allied health professionals and front-line care workers).
5. Resident with Dementia (RwD) Is aged ≥60 years.
6. RwD Is a permanent resident of a participating care home.
7. RwD Has received a clinical diagnosis of dementia or has evidence of dementia as per care home staff
8. RwD Has mild to moderate stage of dementia as indicated by a score of 1 or 2 on the Clinical Dementia Rating global score (CDR)
9. RwD if taking cognitive enhancing medication (i.e., cholinesterase inhibitors or memantine), this must on a stable, unchanged dose for at least 4 weeks prior to screening.
10. RwD is willing to participate in the study and will accept the SSI-C.
11. RwD has mental capacity to give informed consent to participate in the study or has a nominated consultee (a primary care worker, named at the study start) to provide consent on their behalf.
Participant exclusion criteria1. Care Home Has received a ‘non-compliant’ status on HIQA quality standards at their last inspection.
2. Care Home Has insufficient staff to provide two Sensory Champions to deliver the SSI-C.
3. Care Home Is participating in any other research project involving service model change.
4. Staff has insufficient time allocation to participate in the education sessions of the SSI-C.
5. Staff is intending to change jobs in the next six months.
6. Resident with Dementia (RwD) Is unwilling to participate.
7. RwD has unstable medical or psychiatric condition.
Recruitment start date01/07/2022
Recruitment end date31/12/2022

Locations

Countries of recruitment

  • Ireland

Study participating centre

Mercer's Institute for Successful Ageing (MISA) St. James’s Hospital
31 James's Walk
Rialto
Dublin
D08 E191
Ireland

Sponsor information

Trinity College Dublin
University/education

Trinity Research & Innovation
TCD School of Medicine
Research Office
Dublin
D02 PN40
Ireland

Phone +353 1 896 1000
Email clinicaltrialsponsorship@tcd.ie
Website https://www.tcd.ie/
ROR logo "ROR" https://ror.org/02tyrky19
Welcome Trust - HRB Clinical Research Facility (CRF)
Hospital/treatment centre

H&H Building, Level 2
St James’s Hospital
James’s Street
Dublin
D08 NHY1
Ireland

Phone +353 1 410 3900
Email info@sjhcrf.ie

Funders

Funder type

Government

Health Research Board
Government organisation / Local government
Alternative name(s)
Health Research Board, Ireland, An Bord Taighde Sláinte, HRB
Location
Ireland

Results and Publications

Intention to publish date01/10/2023
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available in accordance with our participant consent agreements. Participant-level data will only shared between the core research team.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article 12/02/2025 13/02/2025 Yes No

Editorial Notes

13/02/2025: Publication reference added.
05/07/2022: The following changes were made to the trial record:
1. The public contact was changed.
2. The public title was changed from "SENSE-Cog CARE Home: hearing and vision support for residents with dementia" to "SENSE-Cog Residential CARE: hearing and vision support for residents with dementia".
3. The scientific title was changed from "SENSE-Cog Care Home: A feasibility study of hearing and vision support to improve quality of life in care home residents with dementia" to "SENSE-Cog Residential CARE: A feasibility study of hearing and vision support to improve quality of life in care home residents with dementia"
4. The acronym was changed from SENSE-Cog Care to SENSE-Cog Residential CARE.
16/06/2022: The following changes have been made:
1. The recruitment start date has been changed from 13/06/2022 to 01/07/2022.
2. The ethics approval has been added.
06/05/2022: The recruitment start date has been changed from 01/05/2022 to 13/06/2022.
22/03/2022: The sponsor email was updated.
09/02/2022: Trial's existence confirmed by Health Research Board